“VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE/THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA” (2016) Prospects in Pharmaceutical Sciences, 14(8), pp. 52–56. doi:10.56782/pps.117.